Price reduction for combinations

A range of combination medicines are due to experience price cuts in the 1 October round of price disclosure measures.The newly advised cuts will affect combination drugs due to experience flow-on price reductions.The 2015 Access and Sustainability amendments to the National Health Act 1953 provide for price disclosure reductions to component drugs to be flowed-on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Sore throat and sinusitis, and the few benefits of antibiotics
Next HMR caps still a concern